JP2018527324A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527324A5
JP2018527324A5 JP2018503213A JP2018503213A JP2018527324A5 JP 2018527324 A5 JP2018527324 A5 JP 2018527324A5 JP 2018503213 A JP2018503213 A JP 2018503213A JP 2018503213 A JP2018503213 A JP 2018503213A JP 2018527324 A5 JP2018527324 A5 JP 2018527324A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
aryl
thiazole
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018503213A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018527324A (ja
JP6867998B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/067506 external-priority patent/WO2017017004A1/en
Publication of JP2018527324A publication Critical patent/JP2018527324A/ja
Publication of JP2018527324A5 publication Critical patent/JP2018527324A5/ja
Application granted granted Critical
Publication of JP6867998B2 publication Critical patent/JP6867998B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018503213A 2015-07-24 2016-07-22 ガンを処置するのに使用するための置換疎水性ベンゼンスルホンアミドチアゾール化合物 Active JP6867998B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15306213.8 2015-07-24
EP15306213 2015-07-24
PCT/EP2016/067506 WO2017017004A1 (en) 2015-07-24 2016-07-22 Substituted hydrophobic benzene sulfonamide thiazole compounds for use in treating cancer

Publications (3)

Publication Number Publication Date
JP2018527324A JP2018527324A (ja) 2018-09-20
JP2018527324A5 true JP2018527324A5 (cg-RX-API-DMAC7.html) 2020-12-17
JP6867998B2 JP6867998B2 (ja) 2021-05-12

Family

ID=53758161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503213A Active JP6867998B2 (ja) 2015-07-24 2016-07-22 ガンを処置するのに使用するための置換疎水性ベンゼンスルホンアミドチアゾール化合物

Country Status (4)

Country Link
US (2) US10815207B2 (cg-RX-API-DMAC7.html)
EP (1) EP3325452B1 (cg-RX-API-DMAC7.html)
JP (1) JP6867998B2 (cg-RX-API-DMAC7.html)
WO (1) WO2017017004A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020104822A1 (en) 2018-11-23 2020-05-28 Grey Wolf Therapeutics Limited Compounds
CN115477626B (zh) * 2021-06-16 2024-08-02 上海璃道医药科技有限公司 N-取代苯基磺酰胺类化合物及其用途
EP4201928A1 (en) 2021-12-21 2023-06-28 Institut National de la Santé et de la Recherche Médicale (INSERM) Benzene sulfonamide thiazole compounds and their use for the treatment of cancers
CN120018842A (zh) * 2022-10-20 2025-05-16 国家医疗保健研究所 用于治疗癌症的联合疗法
WO2025219595A1 (en) * 2024-04-19 2025-10-23 Biper Therapeutics Method for combination treatments using alkynylbenzenesulphonamides for cancer therapy
EP4635480A1 (en) 2024-04-19 2025-10-22 Biper Therapeutics SAS Compositions comprising a benzene sulfonamide thiazole compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2817219B2 (ja) 1988-09-08 1998-10-30 武田薬品工業株式会社 カルバジン酸誘導体、その製造法及び製剤
EP1452530A4 (en) * 2001-12-03 2005-11-30 Japan Tobacco Inc AZOL CONNECTION AND THEIR MEDICAL USE
RU2008128453A (ru) 2005-12-12 2010-01-20 Дженелабс Текнолоджис, Инк. (Us) Соединение n-(5-членных арил)-амидов, фармацевтическая композиция с противовирусной активностью на их основе, способ лечения или профилактики вирусной инфекции с их помощью и способ их получения
WO2008027912A2 (en) 2006-08-28 2008-03-06 Dan Theodorescu Prediction of an agent's or agents' activity across different cells and tissue types
AU2008275918B2 (en) * 2007-07-17 2014-01-30 Rigel Pharmaceuticals, Inc. Cyclic amine substituted pyrimidinediamines as PKC inhibitors
WO2009146013A1 (en) * 2008-03-31 2009-12-03 Georgetown University Myosin light chain phosphatase inhibitors
ES2637407T3 (es) * 2012-11-09 2017-10-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Nuevos compuestos de bencenosulfonamida tiazol

Similar Documents

Publication Publication Date Title
JP2018527324A5 (cg-RX-API-DMAC7.html)
JP2009531322A5 (cg-RX-API-DMAC7.html)
JP2015537020A5 (cg-RX-API-DMAC7.html)
JP2017537940A5 (cg-RX-API-DMAC7.html)
JP2013010793A5 (cg-RX-API-DMAC7.html)
JP2018522866A5 (cg-RX-API-DMAC7.html)
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
JP2016514159A5 (cg-RX-API-DMAC7.html)
RU2011124304A (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
HRP20201985T1 (hr) Piridonski spoj kao c-met inhibitor
EA201990902A1 (ru) Ингибиторы тирозинкиназы брутона
JP2017523169A5 (cg-RX-API-DMAC7.html)
JP2014503574A5 (cg-RX-API-DMAC7.html)
JP2013010792A5 (cg-RX-API-DMAC7.html)
JP2009504763A5 (cg-RX-API-DMAC7.html)
JP2017501237A5 (cg-RX-API-DMAC7.html)
JP2016531126A5 (cg-RX-API-DMAC7.html)
JP2017508782A5 (cg-RX-API-DMAC7.html)
JP2017531619A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2019510034A5 (cg-RX-API-DMAC7.html)
JP2016503797A5 (cg-RX-API-DMAC7.html)
JP2017141277A5 (cg-RX-API-DMAC7.html)
JP2009511508A5 (cg-RX-API-DMAC7.html)
JP2014500265A5 (cg-RX-API-DMAC7.html)